Table 12.1
Characteristics of various insulin analogue preparations
Type Example Onset Peak Duration

Short-acting

Regular/soluble

30–60min

1.5–3hr

4–6hr

Rapid (analogue)

Insulin lispro

 

Insulin aspart

5–30min

 

15–30min

30–90min

 

1–3hr

3–5hr

 

3–5hr

Intermediate acti g

NPH

 

Lente

1–4hr

 

3–4hr

–10hr

 

6–12hr

10–16hr

 

12–18hr

Long-acting

Ultralente

1–4hr

8–16hr

18–22hr

Long-acting (analogue)

Insulin detemir

 

Insulin glargine

2–4hr

 

–2hr

None

 

None

12–20hr

 

20–24hr

Type Example Onset Peak Duration

Short-acting

Regular/soluble

30–60min

1.5–3hr

4–6hr

Rapid (analogue)

Insulin lispro

 

Insulin aspart

5–30min

 

15–30min

30–90min

 

1–3hr

3–5hr

 

3–5hr

Intermediate acti g

NPH

 

Lente

1–4hr

 

3–4hr

–10hr

 

6–12hr

10–16hr

 

12–18hr

Long-acting

Ultralente

1–4hr

8–16hr

18–22hr

Long-acting (analogue)

Insulin detemir

 

Insulin glargine

2–4hr

 

–2hr

None

 

None

12–20hr

 

20–24hr

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close